Creative Medical Technology Holdings Inc
NASDAQ:CELZ

Watchlist Manager
Creative Medical Technology Holdings Inc Logo
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Watchlist
Price: 2.39 USD 7.17% Market Closed
Market Cap: 6.2m USD

Creative Medical Technology Holdings Inc
Operating Income

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Creative Medical Technology Holdings Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Creative Medical Technology Holdings Inc
NASDAQ:CELZ
Operating Income
-$6.1m
CAGR 3-Years
-4%
CAGR 5-Years
-40%
CAGR 10-Years
-90%
Abbvie Inc
NYSE:ABBV
Operating Income
$19.7B
CAGR 3-Years
0%
CAGR 5-Years
9%
CAGR 10-Years
13%
Gilead Sciences Inc
NASDAQ:GILD
Operating Income
$11.3B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
-6%
Amgen Inc
NASDAQ:AMGN
Operating Income
$12.1B
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Income
$4.5B
CAGR 3-Years
2%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Income
$3.9B
CAGR 3-Years
-17%
CAGR 5-Years
4%
CAGR 10-Years
12%
No Stocks Found

Creative Medical Technology Holdings Inc
Glance View

Market Cap
6.2m USD
Industry
Biotechnology

Creative Medical Technologies, Inc. develops novel regenerative medicine and stem cell technologies. The company is headquartered in Phoenix, Arizona. The company went IPO on 2009-05-01. The firm conducts its commercial operations through its subsidiary, Creative Medical Technologies, Inc. (CMT). CMT markets and sells its CaverStem and FemCelz disposable kits utilized by physicians to perform autologous procedures that treat erectile dysfunction and female sexual dysfunction and female sexual dysfunction, respectively. The firm's products include CaverStem, FemCelz, StemSpine, Amniostem, ImmCelz and OvaStem. CaverStem utilizes a patient's own stem cells to treat erectile dysfunction (ED). FemCelz is used for the treatment and procedure for vaginal rejuvenation function.

CELZ Intrinsic Value
Not Available

See Also

What is Creative Medical Technology Holdings Inc's Operating Income?
Operating Income
-6.1m USD

Based on the financial report for Sep 30, 2025, Creative Medical Technology Holdings Inc's Operating Income amounts to -6.1m USD.

What is Creative Medical Technology Holdings Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-90%

Over the last year, the Operating Income growth was -8%. The average annual Operating Income growth rates for Creative Medical Technology Holdings Inc have been -4% over the past three years , -40% over the past five years , and -90% over the past ten years .

Back to Top